Next Article in Journal
Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
Previous Article in Journal
A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(5), 1098; doi:10.3390/ijms18051098

How Ketamine Affects Livers of Pregnant Mice and Developing Mice?

1
School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
2
Hong Kong College of Technology, 2 On Shing Street, Ma On Shan, Shatin, Hong Kong, China
*
Author to whom correspondence should be addressed.
Academic Editor: Johannes Haybaeck
Received: 3 April 2017 / Revised: 15 May 2017 / Accepted: 15 May 2017 / Published: 19 May 2017
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
View Full-Text   |   Download PDF [4402 KB, uploaded 19 May 2017]   |  

Abstract

It is well known that ketamine abuse can induce liver damage in adult addicts, but the effects of ketamine abuse in pregnant mothers on their offspring have received less attention. In this study, we investigated the effects of 5-day ketamine injections (30 mg/kg) to pregnant Institute for Cancer Research (ICR) mice during early gestation or mid-gestation on the aspartate aminotransferase (AST) and alkaline phosphatase (ALP) activities of the mothers and the offspring. We also looked into whether administering ketamine treatment to the mothers had any effects on the extent of fibrosis, cell proliferation and cell death in the livers of the newborns. No significant biochemical differences were found between treatment and control groups in the mothers. In the offspring, ketamine treatment mildly suppressed the gradual increase of hepatic AST activity in neonates during liver maturation. Measurements of hepatic ALP activity and lactic acid dehydrogenase (LDH) immunoreactivity revealed that ketamine treatment may lead to increased cell death. Proliferation of liver cells of the newborns was also retarded as shown by reduced proliferative cell nuclear antigen (PCNA) immunoreactivity in the ketamine groups. No obvious fibrosis was evident. Thus, we demonstrated that ketamine administration to pregnant mice suppressed hepatic development and also induced liver cell death of the offspring. View Full-Text
Keywords: ketamine; pregnant; liver enzyme; cell death; neonate; proliferation ketamine; pregnant; liver enzyme; cell death; neonate; proliferation
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Cheung, H.M.; Chow, T.C.H.; Yew, D.T.W. How Ketamine Affects Livers of Pregnant Mice and Developing Mice? Int. J. Mol. Sci. 2017, 18, 1098.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top